CMBA
CLB icon

C.M. Bidwell & Associates’s Core Laboratories CLB Stock Holding History

C.M. Bidwell & Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-23
Closed -$2K – 316
2017
Q2 		$2K Buy
+23
New +$2.48K ﹤0.01% 280

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

C.M. Bidwell & Associates's CLB Position: Q3 2017 in Review

C.M. Bidwell & Associates sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 23 shares — an estimated $2K sold.

C.M. Bidwell & Associates first reported a position in CLB in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • C.M. Bidwell & Associates reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 23 Core Laboratories shares in Q3 2017, an estimated $2K.
  • C.M. Bidwell & Associates first reported a position in Core Laboratories in Q2 2017 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Core Laboratories position peaked at $2K in Q2 2017.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.